Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer - Chau, I; Brown, G; Cunningham, D (J Clin Oncol, 2006)